Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liu G"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Autorzy:
Zhang L; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Shi FY; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Qin Q; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Liu GX; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Zhang HW; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Yan J; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Tan M; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Wang LZ; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Xue D; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Hu CH; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Zhang Z; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
She JJ; Department of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 May 23; Vol. 44 (5), pp. 402-409.
Typ publikacji:
Journal Article
MeSH Terms:
Inflammation*/classification
Nomograms*
Rectal Neoplasms*/surgery
Biomarkers, Tumor ; Carcinoembryonic Antigen ; Humans ; Lymphocytes ; Neutrophils ; Preoperative Period ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
[Clinical outcomes analysis of fertility-preserving therapy for atypical endometrial hyperplasia and early endometrial carcinoma].
Autorzy:
He YJ; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Wang YQ; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Dai YB; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Zhou R; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Lu Q; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Liu GL; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Wang JL; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Mar 23; Vol. 44 (3), pp. 291-296.
Typ publikacji:
Journal Article
MeSH Terms:
Endometrial Hyperplasia*/drug therapy
Endometrial Hyperplasia*/pathology
Endometrial Hyperplasia*/surgery
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/surgery
Fertility Preservation*
Female ; Fertility ; Humans ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
[Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
Autorzy:
Wang C; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Sun ZQ; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Liu MY; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Zhang JJ; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Liu G; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Feng Y; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Yan YF; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Cui HW; Department of Urology, the Fifth Central Hospital of Tianjin, Tianjin 300450, China.
Li G; Department of Urology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Jun 23; Vol. 43 (6), pp. 691-695.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
[Metastatic pancreatic neuroendocrine tumor with ectopic adrenocorticotropic hormone syndrome: a case report].
Autorzy:
Feng L; Department of Endocrinology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050035, China.
Gao Q
Qi HQ
Liu GH
Zhou WL
Zhai ZJ
Wang Y
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2019 Sep 23; Vol. 41 (9), pp. 718-720.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
ACTH Syndrome, Ectopic/*pathology
Neuroendocrine Tumors/*pathology
Pancreatic Neoplasms/*pathology
ACTH Syndrome, Ectopic/surgery ; Adrenocorticotropic Hormone/blood ; Female ; Humans ; Intestinal Neoplasms ; Middle Aged ; Neuroendocrine Tumors/complications ; Neuroendocrine Tumors/surgery ; Pancreatic Neoplasms/complications ; Pancreatic Neoplasms/surgery
Czasopismo naukowe
Tytuł:
[Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
Autorzy:
Luo D; Department of Respiratory Medicine, the First Hospital Affiliated to AMU, Chongqing 400038, China.
Hu SY; the First Surgical Department, Qingmuguan Central Hospital, Chongqing 400038, China.
Liu GX; Department of Respiratory Medicine, the First Hospital Affiliated to AMU, Chongqing 400038, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Feb 23; Vol. 40 (2), pp. 85-91.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cells*
Tumor Microenvironment*
Carcinoma, Non-Small-Cell Lung/*pathology
Lung Neoplasms/*pathology
Animals ; Antigens, CD ; Bone Marrow/pathology ; Bone Marrow Cells/pathology ; Cadherins/metabolism ; Carcinoma, Non-Small-Cell Lung/blood supply ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/secondary ; Carcinoma, Squamous Cell/blood supply ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/secondary ; Disease Progression ; Down-Regulation ; Epithelial-Mesenchymal Transition ; Humans ; Interleukin-6/metabolism ; Lung Neoplasms/blood supply ; Lung Neoplasms/metabolism ; Mice ; Mice, Inbred NOD
Czasopismo naukowe
Tytuł:
[A randomized controlled study of erlotinib versus pemetrexed combined with cisplatin in neoadjuvant therapy of stage ⅢA EGFR-mutant lung adenocarcinoma].
Autorzy:
Chen WQ; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Li P; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Wang Q; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Zhang YJ; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Li HY; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Jin XT; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Yan S; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Kou GF; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Cai SL; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Liu G; Department of Thoracic Oncosurgery-3, Jilin Province Cancer Hospital, Changchun 130021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Feb 23; Vol. 40 (2), pp. 133-137.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Adenocarcinoma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
ErbB Receptors/*antagonists & inhibitors
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*therapeutic use
Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Adenocarcinoma of Lung ; Cisplatin/administration & dosage ; ErbB Receptors/genetics ; Erlotinib Hydrochloride/administration & dosage ; Feasibility Studies ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Mutation ; Neoadjuvant Therapy ; Pemetrexed/administration & dosage
Czasopismo naukowe
Tytuł:
[Shrinkage mode of the primary breast tumor after neoadjuvant chemotherapy analyzed with part-mount sub-serial sectioning and three-dimensional reconstruction technique].
Autorzy:
Yang T; Breast Cancer Center, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China(Present Unit: Department of Radiotherapy, the First People's Hospital of Lianyungang, Xuzhou Medical College, Lianyungang 222002, China).
Zhang ZP; Breast Cancer Center, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
Sun XY; Department of Pathology, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
Liu G; Breast Cancer Center, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
Mu DB; Department of Pathology, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
Wang YS; Breast Cancer Center, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2016 Apr; Vol. 38 (4), pp. 270-6.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoadjuvant Therapy*
Breast Neoplasms/*drug therapy
Breast Neoplasms/*pathology
Carcinoma, Ductal, Breast/*drug therapy
Carcinoma, Ductal, Breast/*pathology
Tumor Burden/*drug effects
Antineoplastic Combined Chemotherapy Protocols ; Chemotherapy, Adjuvant ; Female ; Humans ; Image Processing, Computer-Assisted/methods ; Lymph Nodes/pathology ; Multivariate Analysis ; Neoplasm, Residual ; Software ; Tomography, X-Ray Computed
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies